Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. It was first approved and indicated for use in treating thalassaemia major in 1994 and had been licensed for use in the European Union for many years while awaiting approval in Canada and in the United States. On 14 October 2011, it was approved for use in the US under the FDA's accelerated approval program.
Read the full article on WikipediaIron overload Clinical criteria: Patient must have thalassaemia major, AND Patient must be unable to take desferrioxamine therapy.
“2 to 3 hours”
Working under the parallel aged-care framework? Aged-care equivalent →